BRIEF published on 06/11/2024 at 16:20, 2 years 4 months ago KeViRx, Inc. Awarded $1.99 Million Grant ARDS KeViRx ALI KVX-053
PRESS RELEASE published on 06/11/2024 at 16:15, 2 years 4 months ago KeViRx, Inc. Awarded $1.99 Million KeViRx, Inc. receives $1.99 million grant from Department of Defense to advance small molecule technology for acute lung injury, targeting ARDS with KVX-053. Details on innovative approach and collaboration for ALI treatment ARDS KeViRx KVX-053 Small Molecule Technology Acute Lung Injury
Published on 10/23/2026 at 02:20, 6 hours 34 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 9 hours 24 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 10 hours 24 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 16 hours 54 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 18 hours 24 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 07:00, 1 hour 53 minutes ago EQS-Adhoc: BB Biotech AG publishes its interim report
Published on 10/23/2026 at 07:00, 1 hour 53 minutes ago ATOSS Software SE: Revenue growth and high profitability in the third quarter put ATOSS on track for another record year
Published on 10/23/2026 at 07:00, 1 hour 53 minutes ago BB Biotech Q3 2026: Positive returns, clinical progress and active portfolio redeployment
Published on 10/23/2026 at 06:45, 2 hours 8 minutes ago GURIT REPORTS SOLID THIRD-QUARTER PERFORMANCE AND REITERATES FULL-YEAR GUIDANCE
Published on 10/22/2026 at 18:00, 14 hours 54 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 14 hours 54 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
Published on 10/22/2026 at 18:00, 14 hours 54 minutes ago H1 2026: marked improvement in operating results
Published on 10/22/2026 at 17:47, 15 hours 6 minutes ago Aéroports de Paris SA - 2026 9-month revenue
